Corbi Fernanda Cristina, Inaoka Riguel Jun, Felix Roberta Spetic, Andrade Valéria C C, Etto Leina Yukari, Vettore André L, Franco Marcello F, Colleoni Gisele W B
Hematology and Hemotherapy Service, Department of Pathology, Federal University of São Paulo, Vila Clementino, São Paulo, Brazil.
Diagn Mol Pathol. 2010 Mar;19(1):40-4. doi: 10.1097/PDM.0b013e3181b0b618.
We aimed to evaluate the amount and quality of the RNA obtained from lymph nodes of non-Hodgkin lymphomas (NHLs) patients using fine-needle aspiration cytology (FNAC), and to develop strategies to overcome eventual technical drawbacks.
Twenty-six patients with NHL and 10 tonsils from children submitted to tonsillectomy underwent FNAC. The aspirates were performed using both cytoaspirator (sample A) and syringe and needle (sample B). The RNA was extracted using Trizol reagent and transcribed with the Superscript kit (Invitrogen). The quality of RNA was verified through the amplification of a beta-actin 155-bp fragment.
Fifty-two NHL and 20 tonsil samples were analyzed. The total amount of RNA in the tonsil samples varied from <1.0 to 6.2 microg with cytoaspirator (A) and from <1.0 to 4.7 microg with syringe and needle (B). The total amount of RNA obtained from NHL varied from <1.0 to 6.5 microg with cytoaspirator (A) and <1.0 to 5.5 microg with syringe and needle. In an attempt to increase the amounts of RNA in each sample, we standardized the polyAPCR technique, which increased by 10 times the amount of cDNA in most of the test and control samples. The efficiency of the reaction was verified through the amplification of beta-actin, in which 100% of the test and control samples were amplified. When polyAPCR cDNA and nonamplified cDNA samples were paired to be evaluated by real-time PCR, using glyceraldehyde-3-phosphate dehydrogenase as the constitutive gene and nuclear factor-kappa B and NFkappaBIA as target genes, there was equivalence in the amplifications of 100% of the 15 evaluated samples.
Our results showed that FNAC, obtained either by cytoaspirator or syringe and needle, is a good source of small amounts of RNA. The polyAPCR technique significantly increased the amount of genomic material, which might be a cDNA source for future gene expression studies.
我们旨在评估使用细针穿刺细胞学检查(FNAC)从非霍奇金淋巴瘤(NHL)患者淋巴结中获取的RNA的量和质量,并制定策略以克服可能存在的技术缺陷。
26例NHL患者以及10例接受扁桃体切除术的儿童扁桃体接受了FNAC。抽吸物分别使用细胞抽吸器(样本A)和注射器及针头(样本B)获取。使用Trizol试剂提取RNA,并使用Superscript试剂盒(Invitrogen)进行转录。通过扩增155 bp的β-肌动蛋白片段来验证RNA的质量。
分析了52个NHL样本和20个扁桃体样本。使用细胞抽吸器(A)时,扁桃体样本中的RNA总量在<1.0至6.2μg之间,使用注射器及针头(B)时在<1.0至4.7μg之间。从NHL中获取的RNA总量,使用细胞抽吸器(A)时在<1.0至6.5μg之间,使用注射器及针头时在<1.0至5.5μg之间。为了增加每个样本中的RNA量,我们对多聚腺苷酸聚合酶链反应(polyAPCR)技术进行了标准化,这使得大多数测试和对照样本中的互补DNA(cDNA)量增加了10倍。通过β-肌动蛋白的扩增验证了反应效率,其中100%的测试和对照样本均被扩增。当将polyAPCR cDNA和未扩增的cDNA样本配对通过实时聚合酶链反应进行评估时,以甘油醛-3-磷酸脱氢酶作为组成型基因,核因子-κB和NFκBIA作为靶基因,15个评估样本中有100%的扩增结果相当。
我们的结果表明,通过细胞抽吸器或注射器及针头获得的FNAC是少量RNA的良好来源。polyAPCR技术显著增加了基因组材料的量,这可能是未来基因表达研究的cDNA来源。